Devyser Diagnostics
DVYSR | FN
Overview
Corporate Details
- ISIN(s):
- SE0016588867 (+1 more)
- LEI:
- 549300RV4Z2K3360CK30
- Country:
- Sweden
- Address:
- Instrumentvägen 19, 126 53 Hägersten
- Website:
- https://devyser.com/
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
Develops innovative genetic testing kits for precision diagnostics. Focused on improving patient outcomes with rapid and reliable results.
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| No filings match the current criteria. | ||||
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-03-14 | Mia Arnhult | Other | Buy | 7,000 | 745,290.00 SEK |
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
Merck KGaA | United States of America | 6MK | |
| Metabolic Nordic AB | Sweden | MBOLIC | ||
|
Modus Therapeutics Holding AB | Sweden | MODTX | |
|
Molecure S.A. | Poland | MOC | |
|
M WINKWORTH PLC | United Kingdom | WINK | |
|
Mycodern Spolka Akcyjna | Poland | MCD | |
|
Nanexa AB | Sweden | NANEXA | |
|
Nanobiotix | France | NANO | |
|
Nanoform Finland OYJ | Finland | NANOFH | |
|
NanoGroup S.A. | Poland | NNG |